Dark

FENC
Fennec Pharmaceuticals Inc. Common Stock
stock NASDAQ

At Close

Sep 11, 2026 3:59:48 PM EDT

10.94USD-3.186%(-0.36)249,928

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-11.30)0

After-hours

Sep 10, 2026 4:00:30 PM EDT

11.30USD+0.044%(0.00)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

384.51M

CEO

Rostislav Raykov

Headquarters

Durham, North Carolina, USA

Industry

Biotechnology

Last Split

Aug 30, 20111for17.9986reverse

AMGN GSK BMY JNJ LLY PFE SNY INSY XLV

FENC Stats

Avg. Vol. 10 Day

310,568

Avg. Vol. 30 Day

252,430

Market Cap

384,511,398

Shares Out.

35,067,159

On/Off Exchange

53%/47%

6 Month Beta

1.69

1 Year Beta

1.35

2 Year Beta

1.06

3 Year Beta

0.98

52 Week Low

5.65

52 Week High

13.25

SMA50

11.08

SMA200

8.71

1 Week

-11.50%

1 Month

-7.31%

3 Month

+21.83%

6 Month

+43.71%

1 Year

+25.17%

2 Year

+103.43%

5 Year

+26.33%

Profile

fennec pharmaceuticals inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the united states. its lead product pedmark, a formulation of sodium thiosulfate, which has completed the phase iii clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. the company was formerly known as adherex technologies inc. and changed its name to fennec pharmaceuticals inc. in september 2014. fennec pharmaceuticals inc. was founded in 1996 and is based in research triangle park, north carolina.

FENC Stock Summary

Fennec Pharmaceuticals Inc. Common Stock (NASDAQ:FENC) stock price today is $10.94, and today's volume is 249,928. FENC is down -3.186% today. The 30 day average volume is 252,430. FENC market cap is 384.51M with 35,067,159 shares outstanding.